310 related articles for article (PubMed ID: 27403535)
1. Effects of GlyT1 inhibition on erythropoiesis and iron homeostasis in rats.
Winter M; Funk J; Körner A; Alberati D; Christen F; Schmitt G; Altmann B; Pospischil A; Singer T
Exp Hematol; 2016 Oct; 44(10):964-974.e4. PubMed ID: 27403535
[TBL] [Abstract][Full Text] [Related]
2. Bitopertin, a selective oral GLYT1 inhibitor, improves anemia in a mouse model of β-thalassemia.
Matte A; Federti E; Winter M; Koerner A; Harmeier A; Mazer N; Tomka T; Di Paolo ML; De Falco L; Andolfo I; Beneduce E; Iolascon A; Macias-Garcia A; Chen JJ; Janin A; Lebouef C; Turrini F; Brugnara C; De Franceschi L
JCI Insight; 2019 Nov; 4(22):. PubMed ID: 31593554
[TBL] [Abstract][Full Text] [Related]
3. The mutual control of iron and erythropoiesis.
Camaschella C; Pagani A; Nai A; Silvestri L
Int J Lab Hematol; 2016 May; 38 Suppl 1():20-6. PubMed ID: 27161430
[TBL] [Abstract][Full Text] [Related]
4. [Erythropoietic rate measured by ferrokinetics].
Montz R
Nucl Med (Stuttg); 1970 Mar; 9(1):50-61. PubMed ID: 5505733
[No Abstract] [Full Text] [Related]
5. Preferential hemolysis of immature erythrocytes in experimental iron deficiency anemia: source of erythropoietic bilirubin formation.
Robinson SH; Koeppel E
J Clin Invest; 1971 Sep; 50(9):1847-53. PubMed ID: 5564391
[TBL] [Abstract][Full Text] [Related]
6. NCOA4 Deficiency Impairs Systemic Iron Homeostasis.
Bellelli R; Federico G; Matte' A; Colecchia D; Iolascon A; Chiariello M; Santoro M; De Franceschi L; Carlomagno F
Cell Rep; 2016 Jan; 14(3):411-421. PubMed ID: 26776506
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma transferrin, altered body iron distribution, and microcytic hypochromic anemia in ferrochelatase-deficient mice.
Lyoumi S; Abitbol M; Andrieu V; Henin D; Robert E; Schmitt C; Gouya L; de Verneuil H; Deybach JC; Montagutelli X; Beaumont C; Puy H
Blood; 2007 Jan; 109(2):811-8. PubMed ID: 17003376
[TBL] [Abstract][Full Text] [Related]
8. Anemia and impaired stress-induced erythropoiesis in aceruloplasminemic mice.
Cherukuri S; Tripoulas NA; Nurko S; Fox PL
Blood Cells Mol Dis; 2004; 33(3):346-55. PubMed ID: 15528156
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of hypochromia: the contemporary assessment of iron status and erythropoiesis.
Urrechaga E; Borque L; Escanero JF
Biomed Res Int; 2013; 2013():603786. PubMed ID: 23555091
[TBL] [Abstract][Full Text] [Related]
10. Vitamin A deficiency modulates iron metabolism via ineffective erythropoiesis.
da Cunha MS; Siqueira EM; Trindade LS; Arruda SF
J Nutr Biochem; 2014 Oct; 25(10):1035-44. PubMed ID: 24998947
[TBL] [Abstract][Full Text] [Related]
11. Changes in hepcidin and reticulocyte hemoglobin equivalent levels in response to continuous erythropoietin receptor activator administration in hemodialysis patients: a randomized study.
Kakimoto-Shino M; Toya Y; Kuji T; Fujikawa T; Umemura S
Ther Apher Dial; 2014 Oct; 18(5):421-6. PubMed ID: 24456328
[TBL] [Abstract][Full Text] [Related]
12. In vivo evidence for the functional heterogeneity of transferrin-bound iron. IV. Selective uptake by erythroid precursors of radioiron from portal vein plasma transferrin during intestinal iron absorption.
Okada S; Chipman B; Brown EB
J Lab Clin Med; 1977 Jan; 89(1):51-64. PubMed ID: 830782
[TBL] [Abstract][Full Text] [Related]
13. Non-transferrin-bound iron uptake in Belgrade and normal rat erythroid cells.
Garrick LM; Dolan KG; Romano MA; Garrick MD
J Cell Physiol; 1999 Mar; 178(3):349-58. PubMed ID: 9989781
[TBL] [Abstract][Full Text] [Related]
14. Extracellular glycine is necessary for optimal hemoglobinization of erythroid cells.
Garcia-Santos D; Schranzhofer M; Bergeron R; Sheftel AD; Ponka P
Haematologica; 2017 Aug; 102(8):1314-1323. PubMed ID: 28495915
[TBL] [Abstract][Full Text] [Related]
15. Intestinal iron absorption under the influence of available storage iron and erythroblastic hyperplasia. Comparative studies in children with hereditary spherocytosis, nonspherocytic enzymopenic hemolytic anemia, acquired hemolytic anemia, vitamin B12 deficiency induced megaloblastic anemia, erythroblastic hypoplasia and aplastic anemia.
Bender-Götze C; Heinrich HC; Gabbe EE; Oppitz KH; Schröter W; Whang DH; Schäfer KH
Z Kinderheilkd; 1975; 118(4):283-301. PubMed ID: 1130121
[TBL] [Abstract][Full Text] [Related]
16. Biosynthesis of heme in immature erythroid cells. The regulatory step for heme formation in the human erythron.
Gardner LC; Cox TM
J Biol Chem; 1988 May; 263(14):6676-82. PubMed ID: 3360800
[TBL] [Abstract][Full Text] [Related]
17. Animal models with enhanced erythropoiesis and iron absorption.
Latunde-Dada GO; McKie AT; Simpson RJ
Biochim Biophys Acta; 2006 Apr; 1762(4):414-23. PubMed ID: 16459059
[TBL] [Abstract][Full Text] [Related]
18. Glycine Transporter Type I (GlyT1) Inhibitor, Bitopertin: A Journey from Lab to Patient.
Pinard E; Borroni E; Koerner A; Umbricht D; Alberati D
Chimia (Aarau); 2018 Aug; 72(7):477-484. PubMed ID: 30158010
[TBL] [Abstract][Full Text] [Related]
19. Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.
Millot S; Delaby C; Moulouel B; Lefebvre T; Pilard N; Ducrot N; Ged C; Lettéron P; de Franceschi L; Deybach JC; Beaumont C; Gouya L; De Verneuil H; Lyoumi S; Puy H; Karim Z
Haematologica; 2017 Feb; 102(2):260-270. PubMed ID: 28143953
[TBL] [Abstract][Full Text] [Related]
20. Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity.
Barman-Aksoezen J; Girelli D; Aurizi C; Schneider-Yin X; Campostrini N; Barbieri L; Minder EI; Biolcati G
J Inherit Metab Dis; 2017 May; 40(3):433-441. PubMed ID: 28185024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
